Company to buy
- Size: small-mid size company
- Revenue: more than 5M EUR, maximum 25M EUR
- Location of the target: Europe
- Reason for acquisition: The management decided for expansion in its business sector
- #CFIE PHB012
Overview of this buyer for a generic pharma distributor
The management of a large international pharma generic drugs company is are considering an acquisition of a small/mid-sized company. Currently, the management is looking to enhance its generic drugs production or distribution volume, that is why acquisition is an option. The buyer is looking at targets in all EU and non-EU countries.
Profile (strategy) of this buyer for a generic pharma company in Europe
The buyer is a well-established company based in the DACH region, which specializes in the development, manufacture, and sale of generic niche products in multiple fields, including
The company is large, reaching more than 500M EUR in revenue, and wants to grow externally by M&A. The company has its own laboratory and supplier a large number of hospitals, wholesalers, and pharmacies, domestic and abroad. The company is flexible and constantly invests in the development of new products to meet new market requirements.
The company has already made multiple acquisitions in Europe and Asia, in the pharmaceutical industry. Now they are looking for another acquisition, in a 1-year horizon.
Contact us to get details about this buyer for a generic pharma distributor or manufacturer in europe
Activities and products of the target company
The company is looking for a manufacturing or distribution entity to buy, engaged preferably in generic medicine manufacturing, or front-end distribution (dossiers).
The target should have a stable or growing revenue of 5 to 25M EUR and should have a significant portion of a local pharmaceutical market share. The EBITDA of the target should be more than 15%, preferably around 20%. If target not in debt, it would be of high added value.
The location is not a decisive factor, the target can be from any European country. The target should have all the necessary accreditations. The target plant should ideally be flexible and growing in production volume.
The buyer does not focus on specific drugs/pharmaceuticals/dossiers, rather the management is exploring M&A opportunities present in Europe. Therefore, the management would b happy to consider more opportunities, partly or fully meeting the criteria mentioned above. The range of valuation, which is the buyer willing to spend for acquisition, is between 5 to 40 million EUR.
Highlights of the buyer for a generic pharma company in Europe
- The buyer is a large pharmaceutical company with over half a million EUR of revenue
- The buyer is ready to fund the acquisition out of its own funds, maybe with the help of bank financing in larger projects
- The target should be a manufacturer or front-end distributor with stable positive EBITDA at a reasonable level
More information on this buyer for a generic pharma distributor or manufacturer in europe
Please get in touch if you are interested in learning more about this buyer for a generic pharma distributor or manufacturer in europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.